San Francisco Bay Area biotech stories.
Thursday, May 26, 2011
InSite Vision, Merck, Pfizer sue Sandoz over generic eye drug
Alameda-based InSite Vision said Thursday it joined Merck and Pfizer in suing Sandoz over an antibiotic drug for eye, AzaSite, for which Sandoz is seeking FDA marketing approval.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)